Anti-tumor immune RNA for injection

This product is a tumor-specific immunotherapy drug that can transfer the donor's specific immune response ability to the patient's lymphocytes, thereby enhancing the body's specific humoral and cellular immune response to lung cancer; it also has the ability to mediate cytotoxic effects.

This product is ribonucleic acid extracted from the liver, spleen, lymph nodes and other lymphatic tissues of sheep (cattle) after immunizing healthy sheep (cattle) with corresponding cancer tissues.

This series of products has no drug resistance, no toxic side effects, can enhance the body's immune function, activate the body's immune cells, kill cancer cells, produce specific anti-cancer immune effects, and are used to treat various types of cancer corresponding to the immune cancer tissue used. The effect is better for postoperative patients or when used in combination with radiotherapy and chemotherapy.

Dissolve in 2 ml of water for injection before use, and inject intramuscularly or subcutaneously, 1-4 mg at a time, twice a week or as directed by a doctor, one course of treatment is three months.

It may cause allergic reactions. Most patients may experience mild fever, fatigue and headache. The injection site may cause pain, redness, swelling and even lumps. In severe cases, it should be discontinued.

It is contraindicated for those who are allergic to this product.

Concurrent use with immunosuppressants should be avoided.

Store in a cool dark place.

2mg (anti-nasopharyngeal, anti-intestinal, anti-lung, anti-liver, anti-breast, anti-esophageal, anti-stomach)

Zhejiang Feng'an Bio-pharmaceutical Co., Ltd.

• Founded in:

  2003-01-09

• Address:

  Xiayangdi, Nanfeng Street, Xianju County, Zhejiang Province

• Tax NO.:

  91331024148019787W

• Registered Funds:

  127.79 million yuan

• Email:

  Log in to view